Physician profile
Che Monte Torry
NPI 1326402116
$47,878.44
in general payments reported to CMS, 2019-2025
22 companies · $4,486 in 2025
The $4,486 reported for 2025 was more than what 90% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $357 · 2021: $4,516 · 2022: $8,946 · 2023: $8,563 · 2024: $8,657 · 2025: $4,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $9,842 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,814.39 |
| Food and Beverage | $9,841.80 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,050.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22,671.41 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $12,629.90 | 2019-2020 | |
| Boston Scientific Corporation | $5,765.77 | 2021-2025 | Wavewriter Alpha Prime 16, Spectra Wavewriter, Superion Indirect Decompression System |
| Abbott Laboratories | $2,569.63 | 2021-2025 | Proclaim, Eterna, Octrode |
| Si-Bone, INC. | $1,710.96 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $824.69 | 2022-2025 | Xtampza, Belbuca |
| Globus Medical, INC. | $572.77 | 2025 | Senza |
| Nevro Corp. | $263.26 | 2019-2023 | Senza |
| Tersera Therapeutics LLC | $255.53 | 2021-2025 | Prialt |
| Electronic Waveform Lab, INC. | $130.20 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.51 | 2023-2025 | Relistor |
| Bioventus LLC | $77.39 | 2022-2024 | Gelsyn-3 |
| Fidia Pharma USA INC. | $62.35 | 2020-2024 | Triluron, Hymovis, Hyalgan |
| Curonix LLC | $40.99 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $38.19 | 2023 | Qutenza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $28.69 | 2025 | Korlym |
| Tonix Medicines, INC. | $24.06 | 2025 | Tonmya |
| Painteq LLC | $23.44 | 2024 | Painteq |
| Hikma Pharmaceuticals USA | $21.67 | 2022 | |
| Ferring Pharmaceuticals INC. | $21.18 | 2022 | |
| Avanos Medical | $19.67 | 2025 | Standard Rf Disposables |
| Biodelivery Sciences International, INC. | $15.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Che Torry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.